Monodisperse Poly(lactide-co -glycolic acid)-Based Nanocarriers for Gene Transfection

Multifunctional metal-polymer nanoagglomerates from single-pass aerosol self-assembly

In this study, gold (Au)-iron (Fe) nanoagglomerates were capped by a polymer mixture (PM) consisting of poly(lactide-co-glycolic acid), protamine sulfate, and poly-l-lysine via floating self-assembly in a single-pass aerosol configuration as multibiofunctional nanoplatforms. The Au-Fe nanoagglomerates were directly injected into PM droplets (PM dissolved in dichloromethane) in a collison atomizer and subsequently heat-treated to liberate the solvent from the droplets, resulting in the formation of PM-capped Au-Fe nanoagglomerates. Measured in vitro, the cytotoxicities of the nanoagglomerates (>98.5% cell viability) showed no significant differences compared with PM particles alone (>98.8%), thus implying that the nanoagglomerates are suitable for further testing of biofunctionalities. Measurements of gene delivery performance revealed that the incorporation of the Au-Fe nanoagglomerates enhanced the gene delivery performance (3.2 × 10⁶ RLU mg⁻¹) of the PM particles alone (2.1 × 10⁶ RLU mg⁻¹), which may have been caused by the PM structural change from a spherical to a hairy structure (i.e., the change followed the agglomerated backbone). Combining the X-ray-absorbing ability of Au and the magnetic property of Fe led to magnetic resonance (MR)-computed tomography (CT) contrast ability in a phantom; and the signal intensities [which reached 64 s⁻¹T₂-relaxation in MR and 194 Hounsfield units (HUs) in CT at 6.0 mg mL⁻¹] depended on particle concentration (0.5–6.0 mg mL⁻¹).

Aerosol-based fabrication of modified chitosans and their application for gene transfection

Modified chitosan nanoparticles were conveniently obtained by a one-step aerosol method, and their potential for gene transfection was investigated. Droplets containing modified chitosans were formed by collison atomization, dried to form solid particles, and collected and studied for potential use as nanocarriers. Modified chitosans consisted of a chitosan backbone and an additional component [covalently attached cholesterol; or blends with poly(l-lysine) (PLL), polyethyleneimine (PEI), or poly(ethylene glycol) (PEG)]. Agarose gel retardation assays confirmed that modified chitosans could associate with plasmid DNA. Even though the average cell viability of cholesterol-chitosan (Ch-Cs) showed a slightly higher cytotoxicity (∼90% viability) than that for unmodified chitosan (Cs, ∼95%), transfection (>7.5 × 10(5) in relative light units (RLU) mg(-1)) was more effective than it was for Cs (∼7.6 × 10(4) RLU mg(-1)). The blending of PEI with Cs (i.e., a Cs/PEI) to produce transfection complexes enhanced the transfection efficiency (∼1.3 × 10(6) RLU mg(-1)) more than did the addition of PLL (i.e., a Cs/PLL, ∼9.3 × 10(5) RLU mg(-1)); however, it also resulted in higher cytotoxicity (∼86% viability for Cs/PEI vs ∼94% for Cs/PLL). The average cell viability (∼92%) and transfection efficiency (∼1.9 × 10(6) RLU mg(-1)) were complemented further by addition of PEG in Cs/PEI complexes (i.e., a Cs/PEI-PEG). This work concludes that gene transfection of Cs can be significantly enhanced by adding cationic polymers during aerosol fabrication without wet chemical modification processes of Cs.